Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 13
Submit an article Journal homepage
822
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single center

Patrick YauDepartment of Pharmacy, Tom Baker Cancer Center, Calgary, AB, Canada;
,
Victor H. Jimenez-ZepedaDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, CanadaCorrespondence[email protected]
,
Kyla BaileyDepartment of Pharmacy, Tom Baker Cancer Center, Calgary, AB, Canada;
,
Peter DugganDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
,
Jason TayDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
,
Nizar J. BahlisDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
,
Paola NeriDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
&
Sylvia McCullochDepartment of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada
 show all
Pages 3199-3203 | Received 13 Jan 2019, Accepted 30 May 2019, Published online: 13 Jun 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Alyce M. Kuo, Hani Hassoun, Urvi Shah, Allison Gordon, Travis J. Hollmann, Heather J. Landau, Cecilia Lezcano, Sham Mailankody, Carlyn C. Tan, Alexander M. Lesokhin & Alina Markova. (2022) Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma. Leukemia & Lymphoma 63:9, pages 2233-2237.
Read now
John R Jones, Charlotte Pawlyn & Graham H Jackson. (2021) Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation. Expert Opinion on Drug Safety 20:10, pages 1137-1145.
Read now
Tomiyuki Sugi, Yasuo Nishigami, Hirohisa Saigo, Homare Hanai, Keisuke Takabatake, Mitsuo Mita, Shin Ohara, Shiro Ide, Tomoyuki Uchida, Morihiro Inoue & Masao Hagihara. (2021) Analysis of risk factors for lenalidomide-associated skin rash in patients with multiple myeloma. Leukemia & Lymphoma 62:6, pages 1405-1410.
Read now

Articles from other publishers (6)

Syed B. Ali, Wei-i Lee, Noemi Horvath, Thanh-Thao Adriana Le, William Smith & Pravin Hissaria. (2023) Lenalidomide Desensitization for Delayed Cutaneous Reaction: A Case Series and Review of the Literature. The Journal of Allergy and Clinical Immunology: In Practice 11:5, pages 1503-1508.
Crossref
Oded Shamriz, Elchanan Parnasa, Limor Rubin, Aviv Talmon, Yaarit Ribak, Eyal Lebel, Vladimir Vainstein, Shlomzion Aumann, Revital Saban, Moshe E. Gatt & Yuval Tal. (2023) Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity‐induced rash in patients with multiple myeloma. European Journal of Haematology 110:4, pages 407-413.
Crossref
Georgia J. McCaughan, Sara Gandolfi, John J. Moore & Paul G. Richardson. (2022) Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review. British Journal of Haematology 199:2, pages 190-204.
Crossref
Tomiyuki Sugi, Mitsuo Mita, Takeo Yasu, Shin Ohara, Tomoyuki Uchida, Morihiro Inoue & Masao Hagihara. (2021) Simple desensitization protocol for multiple myeloma patients with lenalidomide‐induced skin rash: Case series. Journal of Clinical Pharmacy and Therapeutics 46:6, pages 1792-1795.
Crossref
Teresa S. Miceli, Wilson I. Gonsalves & Francis K. Buadi. (2021) Supportive care in multiple myeloma: Current practices and advances. Cancer Treatment and Research Communications 29, pages 100476.
Crossref
. (2020) Bortezomib/lenalidomide. Reactions Weekly 1788:1, pages 61-61.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.